Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04218370 · ClinicalTrials.gov registry record · NA
Liberation From Acute Dialysis
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT04218370 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 220 participants.
The verdict
NCT04218370, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge for how to guide delivery of dialysis to facilitate renal recovery.
Interventions
- PROCEDURE Dialysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2020-01-23 |
| Est. Completion | 2025-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04218370
The ClinicalTrials.gov registry entry for NCT04218370 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 220 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dialysis is the first listed.
NCT04218370 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04218370 about?
NCT04218370 is a clinical study titled "Liberation From Acute Dialysis". The goal of the LIBERATE-D clinical trial is to improve outcomes for patients recovering from dialysis-requiring acute kidney injury (AKI-D). The impact of a conservative dialysis strategy compared to standard clinical practice of thrice-weekly dialysis will be examined to help generate knowledge fo...
What is the current status of trial NCT04218370?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2020-01-23. Estimated completion is 2025-06-08.
What interventions are being tested in trial NCT04218370?
The interventions under investigation include: Dialysis (PROCEDURE).
Who is sponsoring clinical trial NCT04218370?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.